Clinical Trials

44 enrolled 16 charts

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT01110876 2021-08-25

Phase I / II Vorinostat, Erlotinib and Temozolomide for Recurrent Glioblastoma Multiforme (GBM)

Phase 1/2 Terminated

21 enrolled 8 charts

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Oligodendroglioma, Gliosarcoma

NCT00509431 2020-07-31

Erlotinib and Sirolimus in Treating Patients With Recurrent Malignant Glioma

19 enrolled

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Oligodendroglioma, Central Nervous System Neoplasms, Gliosarcoma

NCT01103375 2018-08-01

Erlotinib Hydrochloride and Isotretinoin in Treating Patients With Recurrent Malignant Glioma

Phase 1 Terminated

5 enrolled

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Oligodendroglioma, Gliosarcoma

NCT02655536 2018-07-10

BRILLIANT

Phase 2 Unknown

109 enrolled

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung

NCT00301418 2016-02-10

Oral Tarceva Study for Recurrent/Residual Glioblastoma Multiforme and Anaplastic Astrocytoma

Phase 1/2 Completed

11 enrolled 6 charts

CNS

Astrocytoma, Brain Neoplasms, Glioblastoma

NCT01578668 2015-01-26

Erlotinib Plus Pemetrexed to Treat Lung Adenocarcinoma With Brain Metastases

69 enrolled

Adenocarcinoma of Lung, Brain Neoplasms

NCT01763385 2014-12-23

TRACTS

Phase 2 Unknown

210 enrolled

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung

NCT00609999 2014-07-16

Ph I Dasatinib + Erlotinib in Recurrent MG

47 enrolled

Brain Neoplasms, Glioblastoma, Glioma, Gliosarcoma

NCT00385398 2013-09-02

QOL-Stereotactic RadioSurgery, Temozolomide + Erlotinib-Rx of 1-3 Brain Metastases in NSCLC

Phase 2 Withdrawn

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasm Metastasis

NCT00672243 2013-08-07

Ph II Erlotinib + Sirolimus for Pts w Recurrent Malignant Glioma Multiforme

32 enrolled 13 charts

Brain Neoplasms, Glioblastoma, Gliosarcoma

NCT00387894 2013-06-04

Erlotinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma

Phase 2 Terminated

6 enrolled 10 charts

Brain Neoplasms, Glioblastoma, Gliosarcoma

NCT00671970 2013-05-13

Phase (Ph) II Bevacizumab + Erlotinib for Patients (Pts) With Recurrent Malignant Glioma (MG)

57 enrolled 16 charts

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Oligodendroglioma, Gliosarcoma

NCT00738335 2012-10-04

Stereotactic Radiosurgery and Erlotinib in Treating Patients With Non-Small Cell Lung Cancer and Brain Metastases

Phase 1 Withdrawn

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasm Metastasis

NCT00227032 2012-03-06

Erlotinib in Treating Patients With Progressive Glioblastoma Multiforme

Phase 1 Terminated

10 enrolled

Brain Neoplasms, Glioblastoma, Central Nervous System Neoplasms, Gliosarcoma

NCT00554775 2011-12-12

TACTIC

Phase 2 Terminated

80 enrolled

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasm Metastasis

NCT01158170 2010-07-08

Prophylactic Cranial Irradiation in Erlotinib/Gefitinib-responders With Non-small Cell Lung Cancer (NSCLC) (RT1001)

Phase 3 Unknown

200 enrolled

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung

NCT01130779 2010-05-26

The Continuation of Erlotinib

Phase 2 Unknown

23 enrolled

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung

NCT00418327 2009-08-07

Safety Study of Tarceva in Children With Refractory and Relapsed Malignant Brain Tumors and Newly Diagnosed Brain Stem Glioma

48 enrolled

CNS

Brain Neoplasms

NCT00536861 2008-05-29

Safety Study of Radiotherapy and Concurrent Erlotinib (Tarceva®) for Brain Metastases From a Non-Small Cell Lung Cancer

11 enrolled